SCRS’s Jimmy Bechtel on why Bring-Your-Own-Tech is both a protest and a performance differentiator, and what the industry needs to do about it.
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
ON-DEMAND WEBINARS
This on‑demand session offers a clear, practical overview of the major eSignature types used in eConsent — ranging from simple electronic signatures to fully qualified electronic signatures — and explains when each is appropriate.
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
ALS drug development struggles with trial failures due to complex biology and endpoints. Digital health offers sensitive, objective measures to improve clinical trial outcomes collaboratively.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1355432264 data]( "Proven Process For Managing Clinical Trial Changes, Data Migrations")
Proven Process For Managing Clinical Trial Changes, Data MigrationsExplore how the Imperial College London was able to complete a successful migration of 14 ongoing studies, involving over 1,700 patients and 150,000+ forms, within a 16-month timeframe.
-
![GettyImages-1391646149 technology]( "Providing Drug Supply Support In Complex Environments Through IRT")
Providing Drug Supply Support In Complex Environments Through IRTLearn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
![GettyImages-1321462048 AI, research]( "The Importance Of Clinical Research-Focused AI In Data Management")
The Importance Of Clinical Research-Focused AI In Data ManagementEveryone in clinical research is eager to accelerate progress. Learn how to unlock insights from your data swiftly to accelerate the delivery of safe new therapies.
-
![iPad-Medical-Remote-Digital-iStock]( "Simplify Your Clinical Data Flow To Streamline And Automate Modern Data Review")
Simplify Your Clinical Data Flow To Streamline And Automate Modern Data ReviewExamine the three reasons why simplifying your clinical data flow can increase operational oversight, shorten data management cycle times, and reduce the manual burdens on data management teams.
-
![Pill capsule in doctors hand-GettyImages-922565512]( "Managing Drug And Data Requirements In Decentralized Clinical Trials")
Managing Drug And Data Requirements In Decentralized Clinical TrialsRunning a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
![GettyImages-836663414 medical team meeting]( "What Does EDC Look Like In 2024 And Beyond?")
What Does EDC Look Like In 2024 And Beyond?Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.
-
![GettyImages-1176461650 data capture]( "The Electronic Data Capture (EDC) Checklist")
The Electronic Data Capture (EDC) ChecklistWhen running any clinical trial–decentralized, virtual, hybrid, or site-based–there are tools that capture better data faster without sacrificing data quality. One of your most valuable tools will be an Electronic Data Capture (EDC) platform. Access this checklist to discover EDC must-haves during your next clinical trial.
-
![GettyImages-2095562171-data-tech-network]( "GSK And Medable Discuss The Next Phase Of DCTs")
GSK And Medable Discuss The Next Phase Of DCTsGSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
![Solution-GettyImages-1060711170]( "10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them")
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves ThemVendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
![GettyImages-1362491337 Nocturnal Scratch]( "Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch")
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal ScratchThe DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
RECENT NEWSLETTERS
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
